Skip to content
Home/Companies/Pharma/Biovian
Biovian

Biovian

Pharma·France·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Biovian?

Biovian is a French Pharma company, currently owned by Elyan Partners since 2018.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Elyan Partners
Most recent investor
Elyan Partners
ERES III · 2016 · Buyout
2 ownership periods · full history below

Key facts

HQFrance
SectorPharma
Website3pbiovian.com

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by Elyan Partners since 2018.
Co-invest · 2 holders · 2018 · present
Edmond de Rothschild Private Equity (France)
Edmond de Rothschild Private Equity (France)Exited 2024
2018 · 2024(6yr) · Edmond de Rothschild Investment Partners BioDiscovery 4 · 2015 · VC
Recapitalization · to 3P Biopharmaceuticals (combination created 3PBIOVIAN; ERES IV remained a minority shareholder)

Edmond de Rothschild Private Equity (France) sold Biovian to 3P Biopharmaceuticals in 2024 after 6 years.

Elyan Partners
Elyan PartnersActive
2018 · present(8yr) · ERES III · 2016 · Buyout

More from ERES III

Other portfolio companies in the same fund.

Sofatutor
Sofatutor
Active
EdTechGermany· 2021
Tikamoon
Exited 2023
ConsumerFrance· 2021
to LFPI Group
Wella
Wella
Active
ConsumerSwitzerland· 2020
Kepler Cheuvreux
Active
FinancialsFrance· 2018
Allegro.eu
Allegro.eu
Exited 2021
E-commercePoland· 2017
PIB plc
Exited 2021
FinancialsUK· 2017
to Apax Partners

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Biovian?

Biovian is currently owned by Elyan Partners, through ERES III, since 2018.

When did Elyan Partners acquire Biovian?

Elyan Partners acquired Biovian in 2018.

Who did Biovian sell to?

Edmond de Rothschild Private Equity (France) sold Biovian to 3P Biopharmaceuticals in 2024 (Recapitalization).

Who has owned Biovian over time?

Biovian has been through 2 private-equity ownership periods: Edmond de Rothschild Private Equity (France) · via Edmond de Rothschild Investment Partners BioDiscovery 4 · 2018–2024 · sold to 3P Biopharmaceuticals · (Recapitalization); Elyan Partners · via ERES III · since 2018.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue